Xeris Pharmaceuticals, Inc ., Chicago , IL , USA.
Interface Analysis Associates , Saratoga , CA , USA.
Expert Opin Drug Deliv. 2019 Sep;16(9):1015-1025. doi: 10.1080/17425247.2019.1653278.
: Two human factors studies evaluated whether a stable liquid formulation of glucagon in a prefilled syringe (G-PFS) could be safely and effectively administered and evaluated the effectiveness of the product label guide and instructions-for-use (IFU). : In a formative study, 11 participants received orientation with the G-PFS instructional materials and performed a single unaided rescue attempt. In the validation study, 75 adult and adolescent participants received training or familiarized themselves with the G-PFS IFU, Label Guide, and device. All participants returned 1 week later to perform a single unaided rescue attempt of a simulated person with diabetes suffering from an emergency severe hypoglycemic event. : The formative study resulted in a 100% success rate across all rescue dose attempts. The validation study resulted in 74/75 (99%) of participants successfully using the G-PFS to administer the full glucagon rescue dose, and validated that intended users could learn from, comprehend, and recall the G-PFS instructions to successfully use the product. : The G-PFS provides a familiar, easy-to-use alternative to currently marketed lyophilized glucagon kits for treating severe hypoglycemia. The G-PFS IFU and Label Guide enable even untrained users to successfully administer a full rescue dose of stable liquid glucagon.
: 两项人体因素研究评估了预充式注射器中稳定的液体胰高血糖素配方(G-PFS)是否可以安全有效地给药,并评估了产品标签指南和使用说明(IFU)的有效性。 : 在一项形成性研究中,11 名参与者接受了 G-PFS 教学材料的指导,并进行了一次单独的无辅助救援尝试。在验证性研究中,75 名成年和青少年参与者接受了 G-PFS IFU、标签指南和设备的培训或熟悉。所有参与者在一周后返回进行一次单独的无辅助救援尝试,以救助患有紧急严重低血糖事件的模拟糖尿病患者。 : 形成性研究中,所有救援剂量尝试的成功率均为 100%。验证性研究中,74/75(99%)名参与者成功使用 G-PFS 给予全剂量胰高血糖素救援,验证了目标使用者可以从 G-PFS 说明中学习、理解和回忆,从而成功使用该产品。 : G-PFS 为治疗严重低血糖提供了一种熟悉、易于使用的替代目前市售冻干胰高血糖素试剂盒的选择。G-PFS 的 IFU 和标签指南使即使未经训练的用户也能够成功给予全剂量稳定的液体胰高血糖素。